Parkinson's Disease Market

1
Parkinsons Disease
Market Insights, Epidemiology and Market
Forecast- 2028
2
Parkinsons Disease
The hallmarks of the disease are degeneration of
dopaminergic neurons in the substantia nigra pars
compacta of the midbrain and the presence of Lewy
bodies.
Parkinsons disease classification includes
Juvenile Parkinsons Disease, Young-onset
Parkinsons disease, and Idiopathic Parkinsons
Disease. The female-to-male ratio for prevalent
cases is different.
Parkinsons Disease is a progressive condition
involving dysfunction or loss of dopamine
producing neurons in the brain. Dopamine is a
neurotransmitter that aids the bodys ability to
carry out coordinated movement.
The decreased levels of dopamine that underlie
the disease are characterized by difficulty with
both voluntary and involuntary movements. It also
involves non-motor symptoms such as depression,
and orthostatic hypotension.

• DelveInsight 2019 All rights reserved

3
Parkinsons Disease Epidemiology
Parkinsons Disease total prevalent population in
the 7MM countries was observed to be 1,608,367
in 2017 that is expected to reach up to 1,706,922
by 2028, growing at a CAGR of 0.54 for the study
period 20172028.
Based on gender of the prevalent population, it
was observed that more than half of Parkinsons
disease diagnosed prevalent cases were occupied
by males, with 729,965 in the 7MM countries in
2017, while females accounted for nearly 46.86
cases.
Parkinsons disease diagnosed prevalent
population was assessed to be highest for the
United States, accounting for 44.29 of the total
patient pool among the 7MM countries, which is
equivalent to 608,357 cases in 2017.
Among the EU-5 countries, Germany witnessed the
highest diagnosed prevalent population accounting
for more than 25.45 of the total diagnosed
cases, followed by Italy and France whereas Spain
witnessed the lowest number of diagnosed cases in
2017.
Parkinsons Disease total diagnosed prevalent
population ranged from 1,373,639 in 2017 to
1,536,230 in 2028, growing at a CAGR of 1.02 for
the study period 20172028.
7MM includes- United States EU-5 (Germany,
France, Spain, Italy, United Kingdom) Japan.

• DelveInsight 2019 All rights reserved

4
Parkinsons Disease Market
United States Market Size
Market Size in 7MM
Among the 7MM, the United States accounted for
the majority of the market size with USD 941.13
million in 2017.
Parkinsons disease market size in the 7MM is
expected to reach USD 4356.14 million
by 2028 from USD 1837.90 million in 2017.
Germany has the second highest market size after
the United States in 2017, which is accounted
for USD 150.33 million.
Gene therapy, by MeiraGTx Holdings, AAV-GAD is
expected to grab the highest market size with USD
1,609.40 million by 2028
Gene therapy
Germany Market Size

• DelveInsight 2019 All rights reserved

5
Parkinsons Disease Emerging Drugs and Companies
Drug - Istradefylline Company - Kyowa Kirin
Drug - Opicapone Company- Neurocrine Biosciences
Drug - LY03003 Company- Luye Pharma
Drug - P2B001 Company - Pharma Two B Ltd

• DelveInsight 2019 All rights reserved

6
Complete Information
For complete information on Parkinsons
Disease Market Insight, Epidemiology and Market
Forecast - 2028 please click the link below
Click here
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

7
About DelveInsight
VISION
ABOUT
To be the most trusted market research business
consulting firm in the world and to continue
enable the Pharma Bio-Tech companies to achieve
their goals with the best strategic insight and
competitive solution. The vision also is
inclusive of becoming a one-stop solution
provider for the entire gamut of drug development
process.
DelveInsight is a premier Business Consulting and
Market Research firm focused exclusively on the
life science segment. With a wide array of smart
end-to-end solutions, the firm helps the global
Pharmaceutical and Bio-Tech companies formulate
prudent business decisions for improving their
performances to stay ahead of the competitors.
MISSION
MISSION
To provide insights across the value chain and
helping the organization to take a prudent
business decision through the use and analysis of
actionable market intelligence. The mission also
is to provide the most effective result and
efficient service with utmost client care for
maintaining a long-term relationship with them.

• DelveInsight 2019 All rights reserved

8
Services Offerings by DelveInsight
OPPORTUNITY ASSESSMENT
FORECASTING
DELVEINSIGHT
REPORT STORE
PIPELINE
PHARMDELVE
CONSULTING
COMPETITIVE ANALYSIS
MARKET INTELLIGENCE

• DelveInsight 2019 All rights reserved

9
Contact Us
info_at_delveinsight.com
blog/delveInsight/
twitter/delveInsight
91-11-4568 9769
LinkedIn/delveInsight
www.delveinsight.com

• DelveInsight 2019 All rights reserved

10
THANK YOU